NHU(SZ:002001)2022-11-21 15:42Group 1: Financial Performance - The company achieved a revenue of 10.516 billion CNY in the first three quarters, representing a year-on-year increase of 40.72% [1] - Net profit attributable to shareholders reached 3.366 billion CNY, with a year-on-year growth of 14.67% [1] - Total equity attributable to shareholders was 20.870 billion CNY, reflecting a growth of 7.93% compared to the end of the previous year [1] Group 2: Product Development and Capacity - The company has a production capacity of 150,000 tons for methionine, with an additional 150,000 tons under construction, delayed to 2023 due to the pandemic [2] - The PPS (polyphenylene sulfide) production capacity is currently 15,000 tons, with an expansion project of 7,000 tons underway, aiming for a total capacity of 30,000 tons [3] - The company is expanding its product range in the flavor and fragrance sector, with ongoing construction of the menthol project [2] Group 3: Market Outlook and Strategy - The demand for vitamins is stable with seasonal fluctuations, and the company expects to enhance performance through diverse product offerings [2] - The global methionine market is experiencing stable growth, with the company confident in leveraging scale effects and improving product quality [2] - The company is focusing on the bio-fermentation sector, aligning with its strategic goals and emphasizing green and sustainable practices [3] Group 4: Cost Management - Sales expenses have significantly decreased due to the reclassification of certain costs into operating expenses, in accordance with accounting standards [4]